Industry Collaborations

Drug design for Diabetes (type 1 and 2)

Small molecule drug design

Interested in our patented cell-conjugation technology

Machine learning method to design and synthesize immunomodulators

Data-based drug discovery and immunomodulation

Interactome-based drug design technology

Cell-drug conjugation methods we are developing for immune cells

SBIR/STTR - Design and synthesis of compounds to combat HIV

Funding for peptide aggregation modeling

NSF SBIR Funding for COVID-19 distributed blockchain implementation